| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Director | Stock Option (right to buy) | 0 | $28,348 | $3.35 | 05 Dec 2025 | Direct |
| Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 12 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | 05 Dec 2025 | 3 | $0 | 4 | Director | 05 Dec 2025, 09:04 |
| MURA | Mural Oncology plc | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 08:00 |
| MURA | Mural Oncology plc | 30 May 2024 | 1 | $0 | 4/A | Director | 05 Jun 2024, 16:13 |
| MURA | Mural Oncology plc | 30 May 2024 | 1 | +$28,348 | 4 | Director | 03 Jun 2024, 10:20 |
| MURA | Mural Oncology plc | 14 Dec 2023 | 1 | $0 | 4 | Director | 18 Dec 2023, 16:30 |
| MURA | Mural Oncology plc | 31 Oct 2023 | 0 | $0 | 3 | Director | 07 Nov 2023, 16:33 |
| /report/000117911022003008-cuss-francis-m-2022-05-12 | Rubius Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 13 May 2022, 16:31 |
| /report/000117911021005313-cuss-francis-m-2021-05-12 | Rubius Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 20:34 |